Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...
Sept 19 (Reuters) - Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's (MDT.N), opens new tab patent rights in nerve-stimulation ...
MedPage Today on MSN
FDA Approves Nerve Stimulator for Bladder Control
Inserted near the ankle in a minimally invasive procedure, the device generates low-level electronic impulses that stimulate ...
Analysts said Altaviva is an attractive option compared to rival products, informing their belief that Medtronic can ...
Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback